Physician profile
Albert Pope
NPI 1164158127
$704.61
in general payments reported to CMS, 2019-2025
15 companies · $97.47 in 2025
The $97.47 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $54.70 · 2023: $274 · 2024: $279 · 2025: $97.47.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $650.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $649.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $289.60 | 2022-2025 | Mounjaro, Zepbound, Jardiance |
| Abbvie INC. | $129.70 | 2023-2025 | |
| Boston Scientific Corporation | $55.82 | 2024-2025 | Wavewriter Alpha Prime 16 |
| Amgen INC. | $44.81 | 2023-2025 | Otezla, Repatha, Evenity |
| Novo Nordisk INC | $33.43 | 2022-2024 | Ozempic, Rybelsus |
| Janssen Pharmaceuticals, INC | $19.99 | 2024 | Xarelto |
| Biogen, INC. | $18.43 | 2024 | |
| Radius Health, INC. | $17.84 | 2025 | Tymlos |
| Glaxosmithkline, LLC. | $16.64 | 2024 | Shingrix |
| Dexcom, INC. | $15.78 | 2024 | Dexcom G6 Transmitter |
| Inspire Medical Systems, INC. | $14.28 | 2024 | Inspire |
| Exact Sciences Corporation | $14.26 | 2023 | Cologuard Collection Kit |
| Astrazeneca Pharmaceuticals LP | $14.16 | 2024 | Breztri |
| Pfizer INC. | $13.89 | 2024 | |
| Organon LLC | $5.98 | 2025 | Nexplanon |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Albert Pope listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.